|
PWP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.27519999904413E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.2605995681223E-10 |
| Normal-vs-Stage2 |
3.465600E-02 |
| Normal-vs-Stage3 |
2.329600E-02 |
| Normal-vs-Stage4 |
8.999300E-04 |
| Stage1-vs-Stage2 |
4.055600E-02 |
| Stage1-vs-Stage3 |
6.398900E-03 |
| Stage1-vs-Stage4 |
4.430400E-01 |
| Stage2-vs-Stage3 |
8.274400E-01 |
| Stage2-vs-Stage4 |
3.560600E-01 |
| Stage3-vs-Stage4 |
1.890220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.08290000300215E-08 |
| Normal-vs-AfricanAmerican |
4.864000E-01 |
| Normal-vs-Asian |
2.888200E-01 |
| Caucasian-vs-AfricanAmerican |
3.922200E-03 |
| Caucasian-vs-Asian |
7.844600E-01 |
| AfricanAmerican-vs-Asian |
3.537600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.57990000004826E-06 |
| Normal-vs-Female |
1.22019999992951E-07 |
| Male-vs-Female |
2.836400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.974300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.5258000000129E-06 |
| Normal-vs-Age(61-80Yrs) |
3.15540000017656E-07 |
| Normal-vs-Age(81-100Yrs) |
2.619000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.511400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.366600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.953000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.420800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.456000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.797400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.38200000000277E-05 |
| Normal-vs-Grade 2 |
3.4295011275276E-11 |
| Normal-vs-Grade 3 |
7.972900E-04 |
| Normal-vs-Grade 4 |
9.532000E-02 |
| Grade 1-vs-Grade 2 |
5.508800E-01 |
| Grade 1-vs-Grade 3 |
9.586100E-02 |
| Grade 1-vs-Grade 4 |
1.001760E-01 |
| Grade 2-vs-Grade 3 |
8.849700E-04 |
| Grade 2-vs-Grade 4 |
8.843200E-03 |
| Grade 3-vs-Grade 4 |
5.522800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.64313007644523E-14 |
| Normal-vs-ccB subtype |
1.575630E-02 |
| ccA subtype-vs-ccB subtype |
2.57559999994328E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.32430000030237E-07 |
| Normal-vs-N1 |
2.030400E-01 |
| N0-vs-N1 |
9.048600E-01 |
|
|
